TGM7
gene geneOn this page
Also known as TGMZ
Summary
TGM7 (transglutaminase 7, HGNC:30790) is a protein-coding gene on chromosome 15q15.2, encoding Protein-glutamine gamma-glutamyltransferase Z (Q96PF1). Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.
Transglutaminases (TGM; EC 2.3.2.13) are a family of structurally and functionally related enzymes that stabilize protein assemblies through the formation of gamma-glutamyl-epsilon lysine crosslinks. For additional background information on transglutaminases, see TGM1 (MIM 190195).
Source: NCBI Gene 116179 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 123 total
- MANE Select transcript:
NM_052955
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30790 |
| Approved symbol | TGM7 |
| Name | transglutaminase 7 |
| Location | 15q15.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TGMZ |
| Ensembl gene | ENSG00000159495 |
| Ensembl biotype | protein_coding |
| OMIM | 606776 |
| Entrez | 116179 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000452443, ENST00000562372
RefSeq mRNA: 1 — MANE Select: NM_052955
NM_052955
CCDS: CCDS32213
Canonical transcript exons
ENST00000452443 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001045952 | 43293449 | 43293631 |
| ENSE00001147370 | 43276862 | 43276995 |
| ENSE00001147376 | 43279117 | 43279277 |
| ENSE00001147380 | 43279625 | 43279951 |
| ENSE00001147386 | 43281844 | 43282086 |
| ENSE00001147390 | 43282517 | 43282620 |
| ENSE00001147397 | 43284814 | 43284952 |
| ENSE00001147401 | 43287280 | 43287457 |
| ENSE00001147404 | 43287541 | 43287669 |
| ENSE00001147405 | 43291979 | 43292097 |
| ENSE00001147409 | 43292709 | 43292954 |
| ENSE00001600449 | 43302241 | 43302255 |
| ENSE00003465974 | 43276271 | 43276614 |
Expression profiles
Bgee: expression breadth broad, 66 present calls, max score 85.02.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0023 / max 3.2212, expressed in 1 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 149602 | 0.0023 | 1 |
Top tissues by expression
217 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 85.02 | gold quality |
| oocyte | CL:0000023 | 84.95 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.51 | gold quality |
| gingival epithelium | UBERON:0001949 | 75.17 | silver quality |
| left testis | UBERON:0004533 | 70.95 | gold quality |
| gingiva | UBERON:0001828 | 68.91 | silver quality |
| right testis | UBERON:0004534 | 68.88 | gold quality |
| testis | UBERON:0000473 | 67.88 | gold quality |
| sperm | CL:0000019 | 65.31 | gold quality |
| colonic epithelium | UBERON:0000397 | 63.38 | gold quality |
| gastrocnemius | UBERON:0001388 | 58.25 | gold quality |
| amniotic fluid | UBERON:0000173 | 56.45 | gold quality |
| muscle of leg | UBERON:0001383 | 53.91 | gold quality |
| tonsil | UBERON:0002372 | 50.25 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 48.60 | gold quality |
| mammalian vulva | UBERON:0000997 | 47.38 | gold quality |
| thymus | UBERON:0002370 | 47.07 | gold quality |
| vagina | UBERON:0000996 | 46.48 | gold quality |
| bone marrow cell | CL:0002092 | 46.24 | gold quality |
| esophagus mucosa | UBERON:0002469 | 45.04 | gold quality |
| body of tongue | UBERON:0011876 | 44.39 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| prostate gland | UBERON:0002367 | 43.35 | gold quality |
| superior surface of tongue | UBERON:0007371 | 43.31 | gold quality |
| tongue | UBERON:0001723 | 42.94 | gold quality |
| lower lobe of lung | UBERON:0008949 | 42.68 | silver quality |
| quadriceps femoris | UBERON:0001377 | 42.59 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 42.29 | gold quality |
| myocardium | UBERON:0002349 | 42.20 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): EGR1
miRNA regulators (miRDB)
6 targeting TGM7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-6818-3P | 98.56 | 68.23 | 1307 |
| HSA-MIR-505-5P | 97.01 | 65.54 | 778 |
| HSA-MIR-103B | 95.51 | 66.85 | 441 |
Literature-anchored findings (GeneRIF, showing 1)
- Then, using the most efficient peptide, Z3S, we established an in vitro assay system to assess enzymatic activity of TG7. (PMID:23876241)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tgm8 | ENSDARG00000097651 |
| danio_rerio | tgm5l | ENSDARG00000098837 |
| mus_musculus | Tgm7 | ENSMUSG00000079103 |
| rattus_norvegicus | Tgm7 | ENSRNOG00000037203 |
Paralogs (8): TGM1 (ENSG00000092295), TGM5 (ENSG00000104055), F13A1 (ENSG00000124491), TGM3 (ENSG00000125780), TGM4 (ENSG00000163810), EPB42 (ENSG00000166947), TGM6 (ENSG00000166948), TGM2 (ENSG00000198959)
Protein
Protein identifiers
Protein-glutamine gamma-glutamyltransferase Z — Q96PF1 (reviewed: Q96PF1)
Alternative names: Transglutaminase Z, Transglutaminase-7
All UniProt accessions (1): Q96PF1
UniProt curated annotations — full annotation on UniProt →
Function. Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.
Tissue specificity. Widely expressed.
Cofactor. Binds 1 Ca(2+) ion per subunit.
Similarity. Belongs to the transglutaminase superfamily. Transglutaminase family.
RefSeq proteins (1): NP_443187* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001102 | Transglutaminase_N | Domain |
| IPR002931 | Transglutaminase-like | Domain |
| IPR008958 | Transglutaminase_C | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR013808 | Transglutaminase_AS | Active_site |
| IPR014756 | Ig_E-set | Homologous_superfamily |
| IPR023608 | Transglutaminase_animal | Family |
| IPR036238 | Transglutaminase_C_sf | Homologous_superfamily |
| IPR036985 | Transglutaminase-like_sf | Homologous_superfamily |
| IPR038765 | Papain-like_cys_pep_sf | Homologous_superfamily |
| IPR050779 | Transglutaminase | Family |
Pfam: PF00868, PF00927, PF01841
Enzyme classification (BRENDA):
- EC 2.3.2.13 — protein-glutamine gamma-glutamyltransferase (BRENDA: 68 organisms, 476 substrates, 772 inhibitors, 122 Km, 49 kcat entries)
Substrate kinetics (BRENDA)
60 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| PUTRESCINE | 0.035–9.63 | 13 |
| L-LYSINE | 2.9–15.8 | 6 |
| N-CBZ-GLN-GLY | 12.83–59.5 | 5 |
| HYDROXYLAMINE | 1.37–61.9 | 4 |
| NALPHA-BENZYLOXYCARBONYL-L-GLN-GLY | 11.2–30 | 4 |
| CASEIN | 0.006–0.012 | 3 |
| CBZ-GLN-GLY | 0.0169–5.9 | 3 |
| CBZ-GLN-GLY-OH | 3.53–8.55 | 3 |
| METHYLAMINE | 0.024–0.061 | 3 |
| MONODANSYLCADAVERINE | 0.01–0.034 | 3 |
| N-CARBOXYBENZOYL-L-GLUTAMINYL-GLYCINE | 0.0547–69.4 | 3 |
| PENTYLAMINE | 0.0029–0.0203 | 3 |
| Z-GLN-GLY | 1.8–11.6 | 3 |
| ACETYL-ALPHAS1-CASEIN | 0.0029–0.0032 | 2 |
| GTP | 0.0044–0.01 | 2 |
Catalyzed reactions (Rhea), 1 shown:
- L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L-lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+) (RHEA:54816)
UniProt features (8 total): binding site 4, active site 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96PF1-F1 | 92.41 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 279; 338; 361
Ligand- & substrate-binding residues (4): 401; 403; 450; 455
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOBP_PEPTIDE_CROSS_LINKING, TGANTCA_AP1_C, RGAGGAARY_PU1_Q6, MODULE_95, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, HMGIY_Q6, GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY, MODULE_163, MIR505_5P, GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN, NABA_ECM_REGULATORS, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP, GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP, FOXM1_01
GO Biological Process (1): peptide cross-linking (GO:0018149)
GO Molecular Function (5): protein-glutamine gamma-glutamyltransferase activity (GO:0003810), metal ion binding (GO:0046872), protein binding (GO:0005515), transferase activity (GO:0016740), acyltransferase activity (GO:0016746)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification process | 1 |
| aminoacyltransferase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| cation binding | 1 |
| binding | 1 |
| catalytic activity | 1 |
| transferase activity | 1 |
Protein interactions and networks
STRING
462 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TGM7 | PLEKHG5 | O94827 | 507 |
| TGM7 | KLHL6 | Q8WZ60 | 487 |
| TGM7 | KLHL7 | Q8IXQ5 | 456 |
| TGM7 | ZMYM3 | Q14202 | 453 |
| TGM7 | LHFPL5 | Q8TAF8 | 415 |
| TGM7 | KRTAP19-7 | Q3SYF9 | 370 |
| TGM7 | DMTN | Q08495 | 350 |
| TGM7 | GRAMD2A | Q8IUY3 | 338 |
| TGM7 | DCST1 | Q5T197 | 324 |
| TGM7 | LRP1B | Q9NZR2 | 323 |
| TGM7 | SFTA3 | P0C7M3 | 323 |
| TGM7 | VMO1 | Q7Z5L0 | 320 |
| TGM7 | CD47 | Q08722 | 318 |
| TGM7 | OR6X1 | Q8NH79 | 311 |
| TGM7 | OR13J1 | Q8NGT2 | 305 |
IntAct
65 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TGM7 | PPCDC | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPCDC | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCTD1 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FRS3 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNXB | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID5A | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA18 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| HNRNPF | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| QARS1 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDS | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT39 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GEM | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM7 | TSSK3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAB2 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM7 | UNKL | psi-mi:“MI:0915”(physical association) | 0.560 |
| LNX1 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM7 | LAMTOR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO4 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPRY1 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TGM7 | HGS | psi-mi:“MI:0914”(association) | 0.350 |
| TGM7 | KCTD1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FRS3 | TGM7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TNXB | TGM7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TGM7 | ARID5A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), TGM7 (Two-hybrid), PPP1R32 (Two-hybrid), TSSK3 (Two-hybrid), SPATA18 (Two-hybrid), SPRY1 (Two-hybrid), GEM (Two-hybrid), TNXB (Two-hybrid)
ESM2 similar proteins: A0A1W2PQ27, A0A1W2PQ64, A0A1W2PQC6, A0A1W2PQD8, A0A1W2PQJ5, A0A1W2PR75, A2AV36, A4QN59, A6QQV6, D4A1F2, F1RA39, G5E8F4, J9SQF3, O00142, O42868, O55239, O95050, O95932, O97972, P0CR76, P0CR77, P10938, P40261, P40936, P53538, Q01841, Q22453, Q32LP9, Q4R7D0, Q566Y1, Q5M9G7, Q5RFR7, Q5U4E8, Q5XG58, Q62160, Q6C195, Q6CQ61, Q6DE00, Q6FMU7, Q6PCI6
Diamond homologs: A6QP57, D4A5U3, O08619, O43548, O46510, O95932, P00488, P08587, P16452, P21980, P21981, P22735, P22758, P23606, P49221, P51176, P52181, P52183, Q01841, Q05187, Q08188, Q08189, Q8BH61, Q8BZH1, Q96PF1, Q99041, Q9D7I9, Q9GLK0, Q9JLF6, Q9WVJ6, P49222, P12260
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
123 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 109 |
| Likely benign | 10 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2142 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:43276610:CAAGG:C | acceptor_gain | 1.0000 |
| 15:43276860:A:AC | donor_gain | 1.0000 |
| 15:43276860:ACT:A | donor_gain | 1.0000 |
| 15:43276860:ACTC:A | donor_gain | 1.0000 |
| 15:43276861:C:CA | donor_gain | 1.0000 |
| 15:43276861:CT:C | donor_gain | 1.0000 |
| 15:43276861:CTC:C | donor_gain | 1.0000 |
| 15:43276861:CTCC:C | donor_gain | 1.0000 |
| 15:43276861:CTCCT:C | donor_gain | 1.0000 |
| 15:43276863:C:CA | donor_gain | 1.0000 |
| 15:43276993:CAC:C | acceptor_gain | 1.0000 |
| 15:43276993:CACCT:C | acceptor_loss | 1.0000 |
| 15:43276994:ACCTG:A | acceptor_loss | 1.0000 |
| 15:43276997:T:A | acceptor_loss | 1.0000 |
| 15:43276998:G:C | acceptor_gain | 1.0000 |
| 15:43279173:T:TA | donor_gain | 1.0000 |
| 15:43279174:C:A | donor_gain | 1.0000 |
| 15:43279623:AC:A | donor_gain | 1.0000 |
| 15:43279624:CC:C | donor_gain | 1.0000 |
| 15:43281853:A:AC | donor_gain | 1.0000 |
| 15:43281854:C:CC | donor_gain | 1.0000 |
| 15:43282511:A:AC | donor_gain | 1.0000 |
| 15:43282512:C:CC | donor_gain | 1.0000 |
| 15:43282513:TCA:T | donor_loss | 1.0000 |
| 15:43282515:A:AC | donor_gain | 1.0000 |
| 15:43282516:C:A | donor_loss | 1.0000 |
| 15:43282516:C:CC | donor_gain | 1.0000 |
| 15:43282516:CCA:C | donor_gain | 1.0000 |
| 15:43282617:GTTC:G | acceptor_gain | 1.0000 |
| 15:43282618:TTC:T | acceptor_gain | 1.0000 |
AlphaMissense
4669 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:43287368:A:C | S259R | 0.993 |
| 15:43287368:A:T | S259R | 0.993 |
| 15:43287370:T:G | S259R | 0.993 |
| 15:43293533:G:T | R37S | 0.987 |
| 15:43284909:G:C | F303L | 0.985 |
| 15:43284909:G:T | F303L | 0.985 |
| 15:43284911:A:G | F303L | 0.985 |
| 15:43282596:G:C | C343W | 0.983 |
| 15:43282614:G:C | F337L | 0.983 |
| 15:43282614:G:T | F337L | 0.983 |
| 15:43282616:A:G | F337L | 0.983 |
| 15:43282556:A:G | W357R | 0.982 |
| 15:43282556:A:T | W357R | 0.982 |
| 15:43292095:C:G | D148H | 0.982 |
| 15:43284925:C:G | R298P | 0.981 |
| 15:43282607:A:G | W340R | 0.980 |
| 15:43282607:A:T | W340R | 0.980 |
| 15:43282042:C:A | G385W | 0.978 |
| 15:43287547:A:C | S227R | 0.978 |
| 15:43287547:A:T | S227R | 0.978 |
| 15:43287549:T:G | S227R | 0.978 |
| 15:43282598:A:G | C343R | 0.977 |
| 15:43284919:A:T | V300D | 0.977 |
| 15:43282071:C:T | G375D | 0.976 |
| 15:43282576:A:G | L350P | 0.976 |
| 15:43282585:C:G | R347P | 0.976 |
| 15:43293532:C:G | R37P | 0.975 |
| 15:43287299:G:C | F282L | 0.974 |
| 15:43287299:G:T | F282L | 0.974 |
| 15:43287301:A:G | F282L | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000048500 (15:43291517 T>C), RS1000199967 (15:43303853 A>G), RS1000223377 (15:43297683 G>A), RS1000273599 (15:43304090 G>A,T), RS1000526789 (15:43298944 A>C,G,T), RS1000587307 (15:43302338 C>G,T), RS1000603027 (15:43292721 G>T), RS1000949259 (15:43292903 C>A,G,T), RS1001057702 (15:43302623 G>A,T), RS1001201600 (15:43296299 C>T), RS1001266924 (15:43290281 A>G), RS1001426293 (15:43302847 T>C), RS1001481252 (15:43277674 A>G,T), RS1001638409 (15:43277772 T>C), RS1001649116 (15:43280007 G>A,T)
Disease associations
OMIM: gene MIM:606776 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation, decreases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.